At the time this article was written, Daniel Mungul, Nick Bila, Grace Petr, and Katie Satterberg were students in the PA program at Rush University in Chicago, Ill. Alyssa Knueven is an assistant professor and director of clinical education in the PA program at Rush University. The authors have disclosed no potential conflicts of interest, financial or otherwise.
JAAPA. 2024 Sep 1;37(9):21-26. doi: 10.1097/01.JAA.0000000000000087. Epub 2024 Aug 27.
Serotonin syndrome is a rare, life-threatening toxidrome caused by serotonergic agents. This syndrome classically presents with a combination of mental status changes, autonomic hyperactivity, and neuromuscular abnormalities. However, diagnosing the condition is difficult because of its variable symptoms at presentation. As a result, serotonin syndrome often is underreported, making it harder to understand, recognize, and treat. Patients with this condition may present to primary or urgent care or an ED, and may become acutely symptomatic during an inpatient admission. Clinicians must be able to identify at-risk patients and intervene to prevent potentially lethal complications.
血清素综合征是一种罕见的、危及生命的毒蕈碱样综合征,由血清素能药物引起。该综合征经典表现为精神状态改变、自主神经活性亢进和神经肌肉异常的组合。然而,由于其临床表现的症状多变,因此诊断该病症具有一定难度。因此,血清素综合征的报告往往较少,这使得人们更难以理解、认识和治疗这种疾病。患有这种疾病的患者可能会到初级保健或紧急护理或急诊就诊,并且在住院期间可能会突然出现症状。临床医生必须能够识别出高危患者并进行干预,以预防潜在的致命并发症。